Lyell Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$428K Hold
1,968
0.03% 164
2025
Q4
$450K Buy
1,968
+456
+30% +$104K 0.03% 156
2025
Q3
$350K Sell
1,512
-8
-0.5% -$1.63K 0.03% 170
2025
Q2
$282K Sell
1,520
-95
-6% -$17.7K 0.02% 186
2025
Q1
$338K Hold
1,615
0.03% 165
2024
Q4
$287K Sell
1,615
-56
-3% -$10.3K 0.03% 172
2024
Q3
$330K Hold
1,671
0.03% 172
2024
Q2
$287K Buy
1,671
+64
+4% +$10.6K 0.03% 174
2024
Q1
$293K Buy
1,607
+25
+2% +$4.31K 0.03% 172
2023
Q4
$245K Sell
1,582
-82
-5% -$12K 0.03% 175
2023
Q3
$248K Sell
1,664
-709
-30% -$104K 0.03% 159
2023
Q2
$320K Sell
2,373
-44
-2% -$6.45K 0.04% 154
2023
Q1
$385K Buy
2,417
+60
+3% +$9.17K 0.05% 152
2022
Q4
$381K Buy
2,357
+314
+15% +$48.1K 0.06% 149
2022
Q3
$274K Sell
2,043
-294
-13% -$42.2K 0.05% 159
2022
Q2
$358K Buy
2,337
+261
+13% +$39.9K 0.06% 149
2022
Q1
$336K Buy
2,076
+283
+16% +$41.1K 0.04% 161
2021
Q4
$243K Sell
1,793
-131
-7% -$15.5K 0.03% 170
2021
Q3
$208K Sell
1,924
-27
-1% -$3.08K 0.03% 174
2021
Q2
$220K Sell
1,951
-567
-23% -$63.9K 0.03% 176
2021
Q1
$272K Buy
+2,518
New +$269K 0.04% 158

Other funds holding ABBV

Lyell Wealth Management's ABBV Position: Q1 2026 in Review

Lyell Wealth Management held its AbbVie (ABBV) position steady in Q1 2026 at 1,968 shares worth $428K. The position accounts for 0.03% of the portfolio, ranked #164.

Lyell Wealth Management first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. The position peaked at $450K in Q4 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Lyell Wealth Management held 1,968 shares of AbbVie worth $428K as of Q1 2026.
  • Lyell Wealth Management left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.03% of Lyell Wealth Management's portfolio in Q1 2026, its #164 holding.
  • Lyell Wealth Management first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
  • Lyell Wealth Management's AbbVie position peaked at $450K in Q4 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Lyell Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.